Follow
MITUL SRIVASTAVA, Ph.D.
Title
Cited by
Cited by
Year
Identification of potential molecules against COVID-19 main protease through structure-guided virtual screening approach
L Mittal, A Kumari, M Srivastava, M Singh, S Asthana
Journal of Biomolecular Structure and Dynamics 39 (10), 3662-3680, 2021
1812021
Interplay among structural stability, plasticity, and energetics determined by conformational attuning of flexible loops in PD-1
L Mittal, M Srivastava, A Kumari, RK Tonk, A Awasthi, S Asthana
Journal of Chemical Information and Modeling 61 (1), 358-384, 2021
362021
Molecular dynamics simulation reveals the possible druggable hot-spots of USP7
M Srivastava, C Suri, M Singh, R Mathur, S Asthana
Oncotarget 9 (76), 34289, 2018
352018
Conformational characterization of linker revealed the mechanism of cavity formation by 227G in BVDV RDRP
L Mittal, M Srivastava, S Asthana
The Journal of Physical Chemistry B 123 (29), 6150-6160, 2019
262019
Elucidation of structural determinants delineates the residues playing key roles in differential dynamics and selective inhibition of Sirt1–3
M Singh, M Srivastava, SR Wakode, S Asthana
Journal of Chemical Information and Modeling 61 (3), 1105-1124, 2021
202021
Development of potential proteasome inhibitors against Mycobacterium tuberculosis
R Tyagi, M Srivastava, P Jain, RP Pandey, S Asthana, D Kumar, VS Raj
Journal of Biomolecular Structure and Dynamics 40 (5), 2189-2203, 2022
182022
Binding mode characterization of 13b in the monomeric and dimeric states of SARS-CoV-2 main protease using molecular dynamics simulations
A Kumari, L Mittal, M Srivastava, S Asthana
Journal of Biomolecular Structure and Dynamics 40 (19), 9287-9305, 2022
172022
Molecular dynamics simulations reveal the interaction fingerprint of remdesivir triphosphate pivotal in allosteric regulation of SARS-CoV-2 RdRp
M Srivastava, L Mittal, A Kumari, S Asthana
Frontiers in molecular biosciences 8, 639614, 2021
162021
In-silico interactions of active Phytochemicals with c-MYC EGFR and ERBB2 oncoproteins
V Chandel, M Srivastava, A Srivastava, S Asthana, D Kumar
Chemical Biology Letters 7 (1), 47-54, 2020
152020
Conformational characterization of the co-activator binding site revealed the mechanism to achieve the bioactive state of FXR
A Kumari, L Mittal, M Srivastava, DP Pathak, S Asthana
Frontiers in Molecular Biosciences 8, 658312, 2021
122021
Characterizing (un) binding mechanism of USP7 inhibitors to unravel the cause of enhanced binding potencies at allosteric checkpoint
M Srivastava, L Mittal, A Kumari, AK Agrahari, M Singh, R Mathur, ...
Protein Science 31 (9), e4398, 2022
102022
Identification of diphenyl furan derivatives via high throughput and computational studies as ArgA inhibitors of Mycobacterium tuberculosis
H Khurana, M Srivastava, D Chaudhary, TP Gosain, R Kumari, AC Bean, ...
International Journal of Biological Macromolecules 193, 1845-1858, 2021
92021
Deciphering the structural determinants critical in attaining the FXR partial agonism
A Kumari, L Mittal, M Srivastava, DP Pathak, S Asthana
The Journal of Physical Chemistry B 127 (2), 465-485, 2023
82023
Identification and validation of potent Mycobacterial proteasome inhibitor from Enamine library
R Tyagi, M Srivastava, B Singh, S Sharma, RP Pandey, S Asthana, ...
Journal of Biomolecular Structure and Dynamics 40 (19), 8644-8654, 2022
42022
SARS-CoV-2 envelope protein attain Kac mediated dynamical interaction network to adopt ‘histone mimic’ at BRD4 interface: SARS-CoV-2 hijacking the human …
AK Agrahari, M Srivastava, M Singh, S Asthana
Journal of Biomolecular Structure and Dynamics 41 (24), 15305-15319, 2023
32023
Template entrance channel as possible allosteric inhibition and resistance site for quinolines tricyclic derivatives in RNA dependent RNA polymerase of bovine viral diarrhea virus
M Srivastava, L Mittal, D Sarmadhikari, VK Singh, A Fais, A Kumar, ...
Pharmaceuticals 16 (3), 376, 2023
32023
Computational study of novel inhibitory molecule, 1-(4-((2S,3S)-3-amino-2-hydroxy-4-phenylbutyl)piperazin-1-yl)-3-phenylurea, with high potential to competitively …
PP Sharma, S Kumar, S Srivastava, M Srivastava, B Jee, NY Gorobets, ...
Journal of Biomolecular Structure and Dynamics 40 (20), 10162-10180, 2022
32022
Molecular dynamics simulation reveals new pocket for the design of novel amino acid coupled Sirt1 selective inhibitor
M Singh, M Srivastava, N Purushotham, B Paramesha, SR Wakode, ...
Biophysical Journal 118 (3), 207a, 2020
32020
Identification and validation of potent inhibitor of Escherichia coli DHFR from MMV pathogen box
S Sharma, R Tyagi, M Srivastava, K Rani, D Kumar, S Asthana, VS Raj
Journal of Biomolecular Structure and Dynamics 41 (11), 5117-5126, 2023
22023
Polyphosphate kinase-1 regulates bacterial and host metabolic pathways involved in pathogenesis of Mycobacterium tuberculosis
S Chugh, P Tiwari, C Suri, SK Gupta, P Singh, R Bouzeyen, S Kidwai, ...
Proceedings of the National Academy of Sciences 121 (2), e2309664121, 2024
12024
The system can't perform the operation now. Try again later.
Articles 1–20